Mark Verrill
Newcastle upon Tyne Hospitals NHS Foundation Trust(GB)Freeman Hospital(GB)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Sarcoma Diagnosis and Treatment
Most-Cited Works
- → Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials(2010)742 cited
- → Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study(2017)238 cited
- → Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring(2009)216 cited
- → Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk(2009)197 cited
- → Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial(2009)188 cited
- → Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide(2010)